Sign Out
Use in pregnancy: Ciclosporin is not teratogenic in animals. Experience with Sandimmun in pregnant women, however, is still limited. Data available from organ transplant recipients indicate that, compared with other immunosuppressive therapy, Sandimmun treatment imposes no increased risk of adverse effects on the course and outcome of pregnancy. However, there are no adequate and well-controlled studies in pregnant women, therefore Sandimmun Neoral should be used during pregnancy only if the potential benefit justifies risk to the fetus.
Use in lactation: Ciclosporin passes into breast milk. Mothers receiving treatment with Sandimmun Neoral should not breastfeed.
